CGEM Operating Cash Flow (Statement)
Cullinan Therapeutics Inc · Operating Cash Flow (Statement)
CGEM Operating Cash Flow (Statement)
Latest reported-$159.25Mperiod ending
CGEM TTM Cash from Operations (-$20.90M → -$159.25M)
TTM operating cash flow (statement)
High-resolution chart · PNG
CGEM operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -159,250,000 | |
| -178,640,000 | |
| -175,750,000 | |
| -174,267,000 | |
| -171,529,000 | |
| -150,211,000 | |
| -145,303,000 | |
| -126,808,000 | |
| -126,810,000 | |
| -121,525,000 | |
| -134,275,000 | |
| -141,127,000 | |
| -161,339,000 | |
| -155,753,000 | |
| -126,664,000 | |
| -116,852,000 | |
| -73,050,000 | |
| -63,826,000 | |
| -43,433,000 | |
| -37,698,000 | |
| -36,218,000 | |
| -26,272,000 | |
| -29,772,000 | |
| -25,205,000 | |
| -22,001,000 | |
| -20,831,500 | |
| -20,897,000 |